Pfizer, Inc.

Patient preferences in genetic newborn screening for rare diseases: study protocol (2024) Martin S, Angolini E, Audi J, Bertini E, Bruno LP, Coulter J, Ferlini A, et al. Journal article Sunitinib for Metastatic Renal Cell Carcinoma: Real-World Data from the STAR-TOR Registry and Detailed Literature Review (2024) Uhlig A, Bergmann L, Bögemann M, Fischer T, Goebell P, Leitsmann M, Reichert M, et al. Journal article Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. (2024) Brivio E, Pennesi E, Willemse ME, Huitema AD, Jiang Y, Van Tinteren HD, Van Der Velden VH, et al. Journal article Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis (2023) Fitzgerald O, Behrens F, Barton A, Bertheusen H, Boutouyrie-Dumont B, Coates L, Davies O, et al. Journal article, Review article Axitinib beyond first-line therapy of Metastatic Renal Cell Carcinoma: Real World Data from the STAR-TOR registry (2023) Uhlig A, Uhlig J, Woike M, Fischer T, Trojan L, Bergmann L, Bögemann M, et al. Journal article Response to Letter to the Editor From Viru-Loza and Chavez-Nomberto: "Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort " (2023) Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Ibanez L, Carlsson M, Cutfield W, et al. Journal article, Letter Maximum Acceptable Risk Estimation Based on a Discrete Choice Experiment and a Probabilistic Threshold Technique (2023) Veldwijk J, DiSantostefano RL, Janssen E, Simons G, Englbrecht M, Schölin Bywall K, Radawski C, et al. Journal article MRI underestimates presence and size of knee osteophytes using CT as a reference standard (2023) Roemer F, Engelke K, Li L, Laredo JD, Guermazi A Journal article Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance (2022) Simons G, Janssen EM, Veldwijk J, Disantostefano RL, Englbrecht M, Radawski C, Valor-Mendez L, et al. Journal article Inter-Reader Consistency and Exclusionary Findings During Radiographic Screening for Phase 3 Trials of Tanezumab in Patients With Osteoarthritis. (2022) Guermazi A, Roemer F, Kompel AJ, Diaz LE, Crema MD, Brown MT, Hickman A, et al. Journal article